Generation of multitissue cell-cultivated meat via multidirectional differentiation of stable porcine epiblast stem cells.
Yao Y., Zhu G., Zhi M., Li R., Qin L., Zhang Y.
Animal Study, published in Nat Commun (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Nat Commun (2026)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41771865
- PMCID
- PMC13066626
- DOI
- 10.1038/s41467-026-70177-w
- Citations
- 2
Abstract (original English)
Cell-cultivated meat has emerged as an alternative approach for sustainable protein production, but replicating the texture and complex composition of conventional meat remains a critical challenge. Here, we developed an efficient approach to produce multitissue engineered meat by leveraging a serum- and animal-component-free differentiation system to direct porcine pregastrulation epiblast stem cells toward muscle, adipose, and endothelium with synergistic functions. These three types of cell progenitors demonstrated autonomous intercellular recognition and coculture compatibility in a scaffold-free 3D suspension system, enabling the spontaneous formation of tissue-mimetic spheroids with enhanced cellular multiplication efficiency. The products of multitissue cultivated meat recapitulated the textural properties of conventional pork and allowed for nutritional modulation. This platform overcomes key limitations in currently employed cultured meat technologies by integrating scalable 3D suspension culture with serum-free, species-specific stem cell multidirectional differentiation, providing an avenue for the development of multitissue cell-cultivated meat.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.